Company intelligence / Profile preview
Ceragenix Pharmaceuticals, Inc.
Denver, Colorado, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Developed EpiCeram, a topical non-steroidal skin care cream for atopic dermatitis. Their Ceragenin compounds showed promising in vitro activity against various pathogens including antibiotic-resistant bacteria.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small moleculesTopical creams
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Dr. Reddy's LaboratoriesMegapharm
Beyond the preview
Go deeper on Ceragenix Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ceragenix Pharmaceuticals, Inc..